These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Mucosal Immunity and Protective Efficacy of Intranasal Inactivated Influenza Vaccine Is Improved by Chitosan Nanoparticle Delivery in Pigs. Dhakal S; Renu S; Ghimire S; Shaan Lakshmanappa Y; Hogshead BT; Feliciano-Ruiz N; Lu F; HogenEsch H; Krakowka S; Lee CW; Renukaradhya GJ Front Immunol; 2018; 9():934. PubMed ID: 29770135 [TBL] [Abstract][Full Text] [Related]
12. Amino-Modified Polymer Nanoparticles as Adjuvants to Activate the Complement System and to Improve Vaccine Efficacy in Vivo. Pan Y; Qi Y; Shao N; Tadle AC; Huang Y Biomacromolecules; 2019 Sep; 20(9):3575-3583. PubMed ID: 31415161 [TBL] [Abstract][Full Text] [Related]
13. The impact of size on particulate vaccine adjuvants. Shah RR; O'Hagan DT; Amiji MM; Brito LA Nanomedicine (Lond); 2014 Dec; 9(17):2671-81. PubMed ID: 25529570 [TBL] [Abstract][Full Text] [Related]
14. Orchestrating immune responses: How size, shape and rigidity affect the immunogenicity of particulate vaccines. Benne N; van Duijn J; Kuiper J; Jiskoot W; Slütter B J Control Release; 2016 Jul; 234():124-34. PubMed ID: 27221070 [TBL] [Abstract][Full Text] [Related]
15. Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release. Ilyinskii PO; Roy CJ; O'Neil CP; Browning EA; Pittet LA; Altreuter DH; Alexis F; Tonti E; Shi J; Basto PA; Iannacone M; Radovic-Moreno AF; Langer RS; Farokhzad OC; von Andrian UH; Johnston LP; Kishimoto TK Vaccine; 2014 May; 32(24):2882-95. PubMed ID: 24593999 [TBL] [Abstract][Full Text] [Related]
16. Nanocarriers of antigen proteins for vaccine delivery. Lopes Chaves L; Dourado D; Prunache IB; Manuelle Marques da Silva P; Tacyana Dos Santos Lucena G; Cardoso de Souza Z; Muniz Mendes Freire de Moura P; Nunes Bordallo H; Rocha Formiga F; de Souza Rebouças J Int J Pharm; 2024 Jun; 659():124162. PubMed ID: 38663646 [TBL] [Abstract][Full Text] [Related]
17. Neutral polymer micelle carriers with pH-responsive, endosome-releasing activity modulate antigen trafficking to enhance CD8(+) T cell responses. Keller S; Wilson JT; Patilea GI; Kern HB; Convertine AJ; Stayton PS J Control Release; 2014 Oct; 191():24-33. PubMed ID: 24698946 [TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor 8 agonist nanoparticles mimic immunomodulating effects of the live BCG vaccine and enhance neonatal innate and adaptive immune responses. Dowling DJ; Scott EA; Scheid A; Bergelson I; Joshi S; Pietrasanta C; Brightman S; Sanchez-Schmitz G; Van Haren SD; Ninković J; Kats D; Guiducci C; de Titta A; Bonner DK; Hirosue S; Swartz MA; Hubbell JA; Levy O J Allergy Clin Immunol; 2017 Nov; 140(5):1339-1350. PubMed ID: 28343701 [TBL] [Abstract][Full Text] [Related]
19. Micro- and nanoparticulates for DNA vaccine delivery. Farris E; Brown DM; Ramer-Tait AE; Pannier AK Exp Biol Med (Maywood); 2016 May; 241(9):919-29. PubMed ID: 27048557 [TBL] [Abstract][Full Text] [Related]
20. Synergistic effect of dual targeting vaccine adjuvant with aminated β-glucan and CpG-oligodeoxynucleotides for both humoral and cellular immune responses. Jin JW; Tang SQ; Rong MZ; Zhang MQ Acta Biomater; 2018 Sep; 78():211-223. PubMed ID: 30098441 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]